SCHEMBL6707955

SCHEMBL6707955

Cc1cccc(CC(=O)Nc2cccc3cc(C(=O)Nc4ccc(C#N)cc4-c4noc(=O)[nH]4)[nH]c23)c1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PARP14 Q460N5 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.36
ABCB1 P08183 1/20 0.36
RORC P51449 1/20 0.36
MAPK8 P45983 1/20 0.35
MAPK9 P45984 1/20 0.35
KCNQ2 O43526 1/20 0.35
NSD2 O96028 1/20 0.34
ALDH1A1 P00352 1/20 0.34
PKM P14618 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
PTK2B Q14289 1/20 0.33
BRD4 O60885 1/20 0.33
HDAC1 Q13547 1/20 0.33
ADCY1 Q08828 1/20 0.33
PLA2G7 Q13093 1/20 0.33
ROCK2 O75116 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6713884 0.93 PARP14 (0.39) PARP14RORCNSD2MEN1KMT2A
SCHEMBL6709207 0.93 PARP14 (0.43) PARP14RORCNSD2ALDH1A1HDAC1
SCHEMBL6710006 0.91 PARP14 (0.41) PARP14RORCKCNQ2PKMBRD4
SCHEMBL6710443 0.91 PARP14 (0.41) PARP14ABCB1MAPK8MAPK9KCNQ2
SCHEMBL6709985 0.91 PARP14 (0.43) PARP14MAPK8MAPK9KCNQ2ALDH1A1
SCHEMBL6710454 0.90 PARP14 (0.41) PARP14L3MBTL1MAPK8MEN1KMT2A
SCHEMBL6708747 0.89 PARP14 (0.43) PARP14KCNQ2MEN1KMT2A
SCHEMBL6714135 0.89 PARP14 (0.41) PARP14ABCB1RORCKCNQ2MEN1
SCHEMBL6710270 0.89 NR1H4 (0.39) PARP14RORCALDH1A1PTK2BPLA2G7
SCHEMBL6707895 0.89 PARP14 (0.39) PARP14L3MBTL1RORCALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 PARP14 2597/4885L3MBTL1 2013/4885ABCB1 751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.